Jazz Pharmaceuticals (JAZZ) Tops Q2 EPS by 6c, beats revenue
Go back to Jazz Pharmaceuticals (JAZZ) Tops Q2 EPS by 6c, beats revenue| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 240.07 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $240.07 | 52 Week High | $160.00 | |||
| Open | $240.07 | 52 Week Low | $95.80 | |||
| Day High | $240.07 | P/E | 44.62 | |||
| Day Low | $240.07 | EPS | $5.38 | |||
| Volume | 1,939 | |||||
